Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Molecular diagnostic and predictive tests in the evolution of chronic hepatitis C anti-viral therapies ; volume:12 ; number:2 ; day:12 ; month:11 ; year:2012 ; pages:1-4 ; date:11.2012
BMC infectious diseases ; 12, Heft 2 (12.11.2012), 1-4, 11.2012
- Urheber
-
Colucci, Giuseppe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-12-S2-S8
- URN
-
urn:nbn:de:1111-201603035420
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Colucci, Giuseppe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
New Hepatitis C Therapies
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Antiviral drugs against hepatitis C virus
TRIM5alpha contributes to the anti-viral state
Viral recognition and the antiviral interferon response
SUMOylation in Viral Replication and Antiviral Defense
Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
New Hepatitis C Therapies
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Antiviral drugs against hepatitis C virus
TRIM5alpha contributes to the anti-viral state
Viral recognition and the antiviral interferon response
SUMOylation in Viral Replication and Antiviral Defense
Antiviral therapy in acute viral hepatitis B: why and when
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when
Viral hepatitis
Approaches to anti-viral agents
Necroptosis in anti-viral inflammation
New Hepatitis C Therapies
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Antiviral drugs against hepatitis C virus
TRIM5alpha contributes to the anti-viral state
Viral recognition and the antiviral interferon response